NCT02326454: A trial that was reported late by Light Sciences Oncology
This trial has reported, although it was 1221 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02326454 |
|---|---|
| Title | A Phase 2 Randomised, Double-blind, Placebo Controlled, Study of MR901 in Patients With Moderate to Severe Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2014 |
| Completion date | March 29, 2017 |
| Required reporting date | March 29, 2020, midnight |
| Actual reporting date | Aug. 2, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 1221 |